Antidiabetic activity of ethanolic extract of Mirabilis jalapa roots

International Journal of Pharmacy and Technology

Volumn 3, Issue 1, 2011, Pages 1470-1479

  Sarkar, Piyali ^a   Mahmud, Abdul Kabieo ^a   Mohanty, Jyochhna Priya ^b  

^a SIKKIM UNIVERSITY   (India)

^b HIMALAYAN PHARMACY INSTITUTE   (India)

Author keywords

Antidiabetic; Blood Glucose; Hypoglycemic effect; Mirabilis jalapa; Roots; Streptozotocin

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONE; ALCOHOL; ANTIDIABETIC AGENT; BENZENE; CHLOROFORM; CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHANOL; MIRABILIS JALAPA EXTRACT; PETROLEUM ETHER; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; INSULIN RESISTANCE; MALE; MIRABILIS; MIRABILIS JALAPA; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; RAT; STREPTOZOCIN DIABETES;

EID: 79953890429     PISSN: None     EISSN: 0975766X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Collin, C., Davies P., Mutiboko I.K., Ratcliffe S., Sativex, Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis, Eur. J. Neurol. 2007, Vol 14(3), pp290-296.
2. Silja, V.P., Verma, K.S., Mohan, K.V., Ethno medicinal plant knowledge of the Mullu kuruma tribe of Wayanad district, Kerala. Indian J. of Traditional Knowledge, 2008, Vol 7(4), pp604-612.
3. Sood, S.K., Bhardwaj, R., Lakhanpal, T.N., Ethnic Indian Plants in Cure of Diabetes, Scientific Publishers, Indian, 2005, pp164.
4. Crutchfield, Diane, B., Oral Antidiabetic Agents: Back to the Basics, Geriatric Times, 2003, pp20.
5. Kirkman, M.S., American Diabetes Association, North Beauregard Street, Alexandria, 2009, Vol 120(3), pp212-220.
6. National Institutes of Health, Insulin-Dependent Diabetes, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication, 2000, pp549-600.
7. Kirithikar, K.R., Basu, B.D., An, I.C.S., Indian Medicinal Plants, International book distributors, Dehradun, India, 1995, Vol 1, pp371-372.
8. Nadkarni, K.M., Nadkarni, A.K., Indian Materia Medica, Popular Prakashan, Bombay, India, 1976, Vol 1, pp615-616.
9. Koski, R. R., Practical review of oral antihyperglycemic agents for Type 2 diabetes mellitus, The Diabetes Educator, 2006, Vol 32, pp869-876.
10. World Health Organization, General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine, WHO, Geneva, Switzerland, 2001.
11. Harbone, J.B., Baxter, H.H., Phytochemical Dictionary: A hand Book of Bioactive Compound from plants, Taylor and Francis, Washington, 1993, pp237.
12. Wagner, N., Bladt, S., Zgainski, E.M., Plant drug analysis-A Thin Layer Chromatography Atlas, Berlin Heidelberg, New York, Tokyo, 1984, pp1-3.
13. Walker, C., Antinociceptive activity of Mirabilis jalapa in mice, Journal of Ethnopharmacology, 2008, Vol 120, pp169-175.
14. Punitha, I., Shirwaikar, A., Shirwaikar, A., Antidiabetic activity of benzyl tetra isoquinoline alkaloid berberine in streptozotocin-nicotinamide induced type 2 diabetic rats, Diabetologia Croatica, 2006, Vol 4, pp34.
15. Jarrin, M., Sanchez, H., Fernandez, P., Garcia, A., Lopez, M., Streptozotocin Induced Diabetes in Wistar Rat: Is it a Good Model of Diabetic Retinopathy, Invest Ophthalmol Vis. Sci., 2002, Vol 43, pp1334.